BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marzi A, Menicucci AR, Engelmann F, Callison J, Horne EJ, Feldmann F, Jankeel A, Feldmann H, Messaoudi I. Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation. Front Immunol 2018;9:3071. [PMID: 30723475 DOI: 10.3389/fimmu.2018.03071] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Pinski AN, Messaoudi I. Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity. Curr Opin Virol 2021;51:179-89. [PMID: 34749265 DOI: 10.1016/j.coviro.2021.10.007] [Reference Citation Analysis]
2 O’donnell KL, Gourdine T, Fletcher P, Shifflett K, Furuyama W, Clancy CS, Marzi A. VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern. Vaccines 2022;10:435. [DOI: 10.3390/vaccines10030435] [Reference Citation Analysis]
3 Pinski AN, Messaoudi I. To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity. Microorganisms 2020;8:E1473. [PMID: 32992829 DOI: 10.3390/microorganisms8101473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Woolsey C, Jankeel A, Matassov D, Geisbert JB, Agans KN, Borisevich V, Cross RW, Deer DJ, Fenton KA, Latham TE, Gerardi CS, Mire CE, Eldridge JH, Messaoudi I, Geisbert TW. Immune correlates of postexposure vaccine protection against Marburg virus. Sci Rep 2020;10:3071. [PMID: 32080323 DOI: 10.1038/s41598-020-59976-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Iannetta M, Di Caro A, Nicastri E, Vairo F, Masanja H, Kobinger G, Mirazimi A, Ntoumi F, Zumla A, Ippolito G. Viral Hemorrhagic Fevers Other than Ebola and Lassa. Infect Dis Clin North Am 2019;33:977-1002. [PMID: 31668201 DOI: 10.1016/j.idc.2019.08.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
6 Shan D, Tang X, Liu R, Pan D, Wang X, Ge J, Wen Z, Bu Z. Immunogenicity of a Recombinant VSV-Vectored SARS-CoV Vaccine Induced Robust Immunity in Rhesus Monkeys after Single-Dose Immunization. Virologica Sinica 2022. [DOI: 10.1016/j.virs.2022.01.002] [Reference Citation Analysis]
7 Trovato M, Sartorius R, D'Apice L, Manco R, De Berardinis P. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies. Front Immunol 2020;11:2130. [PMID: 33013898 DOI: 10.3389/fimmu.2020.02130] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
8 Dulin N, Spanier A, Merino K, Hutter JN, Waterman PE, Lee C, Hamer MJ. Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials. Vaccine 2021;39:202-8. [PMID: 33309082 DOI: 10.1016/j.vaccine.2020.11.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fathi A, Dahlke C, Addo MM. Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens. Hum Vaccin Immunother 2019;15:2269-85. [PMID: 31368826 DOI: 10.1080/21645515.2019.1649532] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
10 Malherbe DC, Domi A, Hauser MJ, Meyer M, Gunn BM, Alter G, Bukreyev A, Guirakhoo F. Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection. NPJ Vaccines 2020;5:78. [PMID: 32922962 DOI: 10.1038/s41541-020-00226-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Shifflett K, Marzi A. Marburg virus pathogenesis - differences and similarities in humans and animal models. Virol J 2019;16:165. [PMID: 31888676 DOI: 10.1186/s12985-019-1272-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
12 Olejnik J, Mühlberger E, Hume AJ. Recent advances in marburgvirus research. F1000Res 2019;8:F1000 Faculty Rev-704. [PMID: 31131088 DOI: 10.12688/f1000research.17573.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Marzi A, Jankeel A, Menicucci AR, Callison J, O'Donnell KL, Feldmann F, Pinski AN, Hanley PW, Messaoudi I. Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease. Front Immunol 2021;12:774026. [PMID: 34777392 DOI: 10.3389/fimmu.2021.774026] [Reference Citation Analysis]
14 Marzi A, Reynolds P, Mercado-Hernandez R, Callison J, Feldmann F, Rosenke R, Thomas T, Scott DP, Hanley PW, Haddock E, Feldmann H. Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge. EBioMedicine 2019;49:223-31. [PMID: 31631035 DOI: 10.1016/j.ebiom.2019.09.055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
15 Khizar S, Al-dossary AA, Zine N, Jaffrezic-renault N, Errachid A, Elaissari A. Contribution of magnetic particles in molecular diagnosis of human viruses. Talanta 2022. [DOI: 10.1016/j.talanta.2022.123243] [Reference Citation Analysis]
16 Liu G, Cao W, Salawudeen A, Zhu W, Emeterio K, Safronetz D, Banadyga L. Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector. Pathogens 2021;10:1092. [PMID: 34578125 DOI: 10.3390/pathogens10091092] [Reference Citation Analysis]